Discovery Laboratories, Inc.
(NASDAQ:DSCO)|
0.98 -0.01 (-1.01%) Dec 03 - Close |
|
|
|
After-Hours 0.99 +0.01 (1.02%) Wed, 3 Dec 2008 4:00 PM
- Compare DSCO with:
- View: Line | Candlestick
Company Profile
Discovery Laboratories, Inc.
2600 Kelly Road
Warrington, PA 18976-3622
United States - Map
Phone: (215) 488-9300
Fax: (215) 488-9301
Website: www.discoverylabs.com
State of incorporation: Delaware
CEO: Dr. Robert J. Capetola, Ph.D.
Employees: 122
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Biopharmaceutical company
A biotechnology company, which develops Surfactant Replacement Therapies for respiratory disorders and diseases.
Recent news for DSCO
-
[$$] Biotech Mailbag: All About Alnylam
RealMoney by TheStreet.com - Nov 28 at 6:59 ET
-
DISCOVERY LABORATORIES INC /DE/ Financials
EDGAR Online Financials - Nov 18 at 9:04 ET
-
Discovery Labs to Present At the Lazard Healthcare Conference
GlobeNewswire - Nov 13 at 7:00 ET
-
Updated FDA Decision Date Calendar
Seeking Alpha - Nov 13 at 3:35 ET
-
Motley Fool - Nov 11 at 3:04 ET
-
EDGAR Online - Nov 10 at 5:27 ET
-
DISCOVERY LABORATORIES INC /DE/ Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 10 at 4:09 ET
-
FDA to review Discoverys Surfaxin response
bizjournals.com - Nov 10 at 12:05 ET
-
Discovery shares plunge on Surfaxin review period
AP - Nov 10 at 10:49 ET
-
Backlog of Decisions Is Building at the FDA
Seeking Alpha - Nov 08 at 1:43 ET
Top members owning DSCO
-
Top 89%
-52.27%3m:
-62.65%YTD: